By UWE REINHARDT In a fascinating paper on drug pricing, Ana D. Vega and her five co-authors trace increases in the price of brand-name and generic drugs in the U.S. during the period 2012-15, using the national average drug acquisition costs (NADAC)
Read More...
Read the complete post at http://thehealthcareblog.com/blog/2017/04/10/value-pricing-of-drugs-and-pharmace-pharmaceutical-innovation/
Posted
Apr 10 2017, 10:30 AM
by
THCB